Metastatic Lung Adenocarcinoma
Profile
- 76-year-old male
- Prior Dx: brain metastatic lung cancer
- Currently on osimertinib
- Suspect LMD
- Prior tissue biopsy: EGFR exon 19 deletion/MET amplification/PD-L1+
- Prior plasma liquid biopsy: EGFR exon 19 deletion
Work Up
- Summit molecular profile in CSF
Summit™ Report
- Detects EGFR E746_P753 delinsVS and TP53 E258* variants
- Reports six targeted therapeutic options and averts high-risk biopsy
- Provides diagnostic and prognostic implications per WHO
